I tried to give all of them at RCPI the benefit of the doubt because I don't know all the efforts they made. I did not forget that they participated in all those biopharm events, but I have no idea whom they talked to or how good they were at the sales aspect of it. But it just seems even if you thought you were too important to make cold calls because you're a doctor or a high-powered marketing director, you could pay someone to make calls and to monitor news for research on inflammation. The shareholder who is contacting pharma companies has had (I think at last count) at least five companies request a Power Point presentation. I'd say Rock Creek did a very good job keeping anatabine a secret.
News 
Market Data 
Discover 
